Phase II study of nivolumab and ipilimumab for advanced bladder cancer of variant histologies (BCVH).
暂无分享,去创建一个
T. Choueiri | G. Sonpavde | G. Bubley | A. Venkatesan | B. McGregor | A. Siefker-Radtke | M. Campbell | A. Shah | W. Xie | R. McKay | K. Kilbridge